Dr Kimon Chatzistamatiou is an Academic Consultant and a Gynaecological Oncology Fellow at the 1st Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki (AuTh), Greece. He received his MD (2002) and PhD (2017) from the Medical School of AuTh. He is board-certified in Obstetrics and Gynaecology (2013), in colposcopy and cervical pathology (2014), and has overseen the lower genital tract clinic at “Papageorgiou” General Hospital, Thessaloniki, Greece, for the past four years. For his doctoral thesis, graded “excellent with distinction”, he explored the utility of HPVE7-oncoprotein detection for the triage of women, tested high-risk HPV positive, to colposcopy, and has been the recipient of the University’s award for high academic standards and excellence. Since 2011, he has participated in four nationwide multicenter studies in Greece: • The “LYSISTRATA” study, (HPV epidemiology, HPV vaccination acceptance). • The “HERMES” study, (diagnostic accuracy of HPV primary cervical cancer screening). • The “PIPAVIR” study, funded by the EUFP4, (HPV-DNA testing and HPVE7-oncoprotein detection in cervical cancer screening). • The “GRECOSELF” study, (HPV-DNA primary screening with self-sampling). He is a Board member of the Hellenic HPV Society, an affiliate Board member of the International Papillomavirus Society and a member of the Education Committee of this Society.